About Aurigene Pharmaceutical
Aurigene Pharmaceutical is a company based in Bengaluru (India) founded in 2020. It operates as a B2B and Service-based. The company has 906 employees as of March 31, 2023. Aurigene Pharmaceutical offers products and services including Small Molecule Discovery, Small Molecule CDMO, Biologics Services, and Formulation Services. Aurigene Pharmaceutical operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Bengaluru, India
- Employees 906 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aurigene Pharmaceutical Services Limited
- Date of Incorporation 16 Sep, 2019
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$40.45 M (USD)-7.59as on Mar 31, 2023
-
Net Profit
$1.53 M (USD)-60.33as on Mar 31, 2023
-
EBITDA
$9.16 M (USD)-28.69as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
906
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aurigene Pharmaceutical
Aurigene Pharmaceutical offers a comprehensive portfolio of products and services, including Small Molecule Discovery, Small Molecule CDMO, Biologics Services, and Formulation Services.
Services for chemistry and biology in drug development processes.
Development and production of pharmaceutical intermediates and APIs.
From antibody discovery to clinical manufacturing of biologics.
Development of various dosage forms for pharmaceutical products.
Funding Insights of Aurigene Pharmaceutical
Detailed funding history for Aurigene Pharmaceutical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aurigene Pharmaceutical
Investment portfolio details for Aurigene Pharmaceutical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aurigene Pharmaceutical
Detailed financials for Aurigene Pharmaceutical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aurigene Pharmaceutical Comparisons
Peer comparison for Aurigene Pharmaceutical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aurigene Pharmaceutical
Aurigene Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Aurigene Pharmaceutical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aurigene Pharmaceutical
Complete news archive for Aurigene Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurigene Pharmaceutical
Aurigene Pharmaceutical was founded in 2020.
Aurigene Pharmaceutical is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
As of Mar 31, 2023, the latest employee count at Aurigene Pharmaceutical is 906.
Annual revenue of Aurigene Pharmaceutical is $40.45M as on Mar 31, 2023.
Aurigene Pharmaceutical Services is a global CRDMO specializing in end-to-end solutions for small and large molecules, including drug discovery, development, and manufacturing. It operates through flexible models like FTE and FFS, serving global pharma and biotech clients. Based in India, with facilities in Hyderabad, Bangalore, the UK, and Mexico, it focuses on compliance, sustainability, and innovation in areas like chemistry, biology, and biologics.
Aurigene Pharmaceutical's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Aurigene Pharmaceutical offers Small Molecule Discovery, Small Molecule CDMO, Biologics Services, and Formulation Services.